ijms-logo

Journal Browser

Journal Browser

Heterocyclic Compounds: Synthesis, Design, and Biological Activity

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: 31 July 2025 | Viewed by 767

Special Issue Editor


E-Mail Website
Guest Editor
1. Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 84215 Bratislava, Slovakia
2. Department of Chemical Biology, Faculty of Science, Palacky University, Olomouc, Slechtitelu 27, 78371 Olomouc, Czech Republic
Interests: medicinal chemistry; drug design; structure–activity relationships; pharmaceutical analysis; polymorphism; drug bioavailability; ADME; nanoparticles; nanoformulations; controlled/targeted delivery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Although organic compounds consist of a carbon–hydrogen backbone, heteroatoms provide specificity to this skeleton. It does not matter whether these are classical heteroatoms, such as nitrogen, oxygen, or sulfur; rarer ones, such as phosphorus and selenium; or the various, widely occurring halogen groups. Isosteric/bioisosteric replacement of hydrocarbon fragments by heteroatoms can be carried out both in aliphatic structures and, much more often, in a variety of cyclic systems. Many heterocyclic structures can be considered privileged scaffolds. Heterocycles thus undoubtedly form the basis of any bioactive compounds; according to statistics, more than 85% of all biologically active chemical entities contain a heterocycle. This fact reflects the central role of heterocycles in the modern design of not only drugs but also, for example, agrochemicals. Although there are countless synthetic approaches to the preparation of heterocycles, it should also be mentioned that many heterocyclic agents have been isolated from natural sources. The type, amount, and position of heteroatoms affect not only the chemical and physical properties but also the binding to biological targets and thus the overall biological behavior of these compounds. Knowledge of interactions between molecules and their environment is undoubtedly the driving force of all contemporary biomedical, biological, and ecological sciences, and this knowledge is crucial for the further development and applications of these compounds.

This Special Issue is intended for all scientists involved in the synthesis/isolation, structural aspects, and analysis of heterocycles; the design, discovery, and development of biologically active heterocyclic compounds; and materials and their interactions, including their eco(toxico)logical effects. Both theoretical papers and manuscripts dealing with the mentioned topics experimentally are welcome, as are contributions dealing with the structure of receptors or enzymatic cascades.

Prof. Dr. Josef Jampilek
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • heterocycles
  • bioactive molecules and materials
  • pharmacophore
  • design
  • targeting
  • computer studies
  • synthesis and analysis
  • natural compounds
  • carbohydrates
  • physicochemical properties
  • biological screening

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

21 pages, 4294 KiB  
Article
Novel 5-Oxopyrrolidine-3-carbohydrazides as Potent Protein Kinase Inhibitors: Synthesis, Anticancer Evaluation, and Molecular Modeling
by Ingrida Tumosienė, Maryna Stasevych, Viktor Zvarych, Ilona Jonuškienė, Kristina Kantminienė and Vilma Petrikaitė
Int. J. Mol. Sci. 2025, 26(7), 3162; https://doi.org/10.3390/ijms26073162 - 29 Mar 2025
Viewed by 336
Abstract
A series of novel hydrazones bearing diphenylamine and 5-oxopyrrolidine moieties, along with benzene and naphthalene rings substituted with hydroxy, alkoxy, or carboxylic groups, were synthesized. Their anticancer activity was evaluated in vitro using both 2D (MTT and ‘wound healing’ assays) and 3D (cell [...] Read more.
A series of novel hydrazones bearing diphenylamine and 5-oxopyrrolidine moieties, along with benzene and naphthalene rings substituted with hydroxy, alkoxy, or carboxylic groups, were synthesized. Their anticancer activity was evaluated in vitro using both 2D (MTT and ‘wound healing’ assays) and 3D (cell spheroid) models against human melanoma IGR39 cells, the triple-negative breast cancer cell line MDA-MB-231, and pancreatic carcinoma Panc-1 cell line. Compounds 8 (2-hydroxybenzylidene derivative) and 12 (2-hydroxynaphthalenylmethylene derivative) demonstrated the highest cytotoxicity in both 2D and 3D assays, while compounds 4 (2,5-dimethoxybenzylidene derivative) and 6 (2,4,6-trimethoxybenzylidene derivative) were most effective at inhibiting cell migration. Notably, all compounds exhibited lower activity against the Panc-1 cancer cell line in a cell monolayer, but the effects on spheroid cell viability in 3D models were comparable across all tested cancer cell lines. Molecular docking studies of the most active hydrazones suggested that these compounds may act as multikinase inhibitors. In particular, 2-hydroxynaphthalenylmethylene derivative 12 showed high binding affinity values (−11.174 and −11.471 kcal/mol) to the active sites of two key protein kinases—a non-receptor TK (SCR) and STPK (BRAF)—simultaneously. Full article
(This article belongs to the Special Issue Heterocyclic Compounds: Synthesis, Design, and Biological Activity)
Show Figures

Graphical abstract

Review

Jump to: Research

36 pages, 13579 KiB  
Review
Therapeutic Potential of Tricyclic Pyridazinone-Based Molecules: An Overview
by Battistina Asproni, Gérard A. Pinna, Paola Corona, Silvia Coinu, Sandra Piras, Antonio Carta and Gabriele Murineddu
Int. J. Mol. Sci. 2025, 26(8), 3806; https://doi.org/10.3390/ijms26083806 - 17 Apr 2025
Viewed by 266
Abstract
Pyridazin-3(2H)one-based molecules have always attracted the attention of medicinal chemists due to their different pharmacological properties. The incorporation of such nuclei in therapeutically active molecules either as monocyclic units or as fused bi- or tricyclic scaffolds results in a wide range [...] Read more.
Pyridazin-3(2H)one-based molecules have always attracted the attention of medicinal chemists due to their different pharmacological properties. The incorporation of such nuclei in therapeutically active molecules either as monocyclic units or as fused bi- or tricyclic scaffolds results in a wide range of pharmacological effects such as anti-inflammatory, analgesic, anticancer, antimicrobial, antiviral, cardiovascular-protective, antiulcer, and many other useful pharmacological activities. In accordance with our consolidated experience gained over the years in the chemistry and biology of tricyclic pyridazin-3(2H)ones, this review summarizes SAR studies of such pyridazinone-based polycyclic compounds endowed with various biological and therapeutic properties. Full article
(This article belongs to the Special Issue Heterocyclic Compounds: Synthesis, Design, and Biological Activity)
Show Figures

Figure 1

Back to TopTop